New asthma drug PRA-216 enters early human testing
Symptom relief
Recruiting now
This study tests a new drug, PRA-216, for people with mild-to-moderate asthma. First, healthy volunteers will receive single or multiple doses to check safety. Then, asthma patients will receive the drug to see if it reduces airway inflammation. The goal is to find a safe dose an…
Phase: PHASE1, PHASE2 • Sponsor: Prana Therapies Inc • Aim: Symptom relief
Last updated May 17, 2026 14:00 UTC